RAPT Therapeutics, Inc. Proceeds from Stock Options Exercised
RAPT Therapeutics, Inc. reported Proceeds from Stock Options Exercised of $67.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2025-03-06
- RAPT Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2021-03-31 was $121.00K, a 303.33% increase year-over-year.
- RAPT Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2020-12-31 was $307.00K, a 1435.00% increase year-over-year.
- RAPT Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2020-09-30 was $165.00K, a 75.81% decline year-over-year.
- RAPT Therapeutics, Inc. proceeds from stock options exercised for the quarter ending 2020-06-30 was $453.00K, a 1232.35% increase year-over-year.
- RAPT Therapeutics, Inc. proceeds from stock options exercised for fiscal 2024 was $67.00K, a 86.60% decline from fiscal 2023.
- RAPT Therapeutics, Inc. proceeds from stock options exercised for fiscal 2023 was $500.00K, a 28.57% decline from fiscal 2022.
- RAPT Therapeutics, Inc. proceeds from stock options exercised for fiscal 2022 was $700.00K, a 41.67% decline from fiscal 2021.
- RAPT Therapeutics, Inc. proceeds from stock options exercised for fiscal 2021 was $1.20M, a 25.65% increase from fiscal 2020.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-12-31 | $67.00K 10-K · filed 2025-03-06 | |||
| 2023-12-31 | $500.00K 10-K · filed 2025-03-06 | |||
| 2022-12-31 | $700.00K 10-K · filed 2024-03-07 | |||
| 2021-12-31 | $1.20M 10-K · filed 2023-03-14 | |||
| 2021-03-31 | $121.00K 10-Q · filed 2021-05-11 | $428.00K derived: sum of 2 quarters · filed 2021-05-11 | $593.00K derived: sum of 3 quarters · filed 2021-05-11 | $1.05M derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-12-31 | $307.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $472.00K derived: sum of 2 quarters · filed 2021-03-11 | $925.00K derived: sum of 3 quarters · filed 2021-03-11 | $955.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $165.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $618.00K derived: sum of 2 quarters · filed 2020-11-16 | $648.00K 10-Q · filed 2020-11-16 | $668.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-06-30 | $453.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $483.00K 10-Q · filed 2020-08-13 | $503.00K derived: sum of 3 quarters · filed 2021-05-11 | $1.19M derived: sum of 4 quarters · filed 2021-05-11 |
| 2020-03-31 | $30.00K 10-Q · filed 2021-05-11 | $50.00K derived: sum of 2 quarters · filed 2021-05-11 | $732.00K derived: sum of 3 quarters · filed 2021-05-11 | $766.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $702.00K derived: sum of 2 quarters · filed 2021-03-11 | $736.00K derived: sum of 3 quarters · filed 2021-03-11 | $802.00K 10-K · filed 2021-03-11 |
| 2019-09-30 | $682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $716.00K derived: sum of 2 quarters · filed 2020-11-16 | $782.00K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $100.00K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | $66.00K 10-Q · filed 2020-05-14 |